

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-s...
Q2 2026
Jul 29, 2026
Q1 2026
Apr 27, 2026
FY 2025
Feb 24, 2026
Q4 2025
Feb 24, 2026
Q3 2025
Oct 29, 2025